Algert Global’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-51,577
Closed -$2.17M 1292
2023
Q2
$2.17M Sell
51,577
-21,589
-30% -$873K 0.09% 359
2023
Q1
$2.61M Buy
73,166
+37,588
+106% +$1.36M 0.12% 259
2022
Q4
$1.3M Buy
+35,578
New +$1.41M 0.07% 460
2022
Q2
Sell
-7,634
Closed -$618K 1427
2022
Q1
$618K Sell
7,634
-2,727
-26% -$231K 0.04% 737
2021
Q4
$1.06M Sell
10,361
-2,791
-21% -$268K 0.13% 257
2021
Q3
$1.15M Buy
+13,152
New +$1.19M 0.15% 178
2019
Q4
Sell
-3,917
Closed -$208K 451
2019
Q3
$208K Buy
+3,917
New +$201K 0.08% 278
2017
Q2
Sell
-6,515
Closed -$299K 366
2017
Q1
$299K Sell
6,515
-32,791
-83% -$1.63M 0.08% 262
2016
Q4
$2.07M Buy
39,306
+19,593
+99% +$949K 0.59% 54
2016
Q3
$879K Buy
19,713
+5,015
+34% +$218K 0.25% 164
2016
Q2
$560K Buy
+14,698
New +$646K 0.23% 175

Other funds holding SYNH

Algert Global's SYNH Position: Q3 2023 in Review

Algert Global sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 51,577 shares — an estimated $2.17M sold.

Algert Global first reported a position in SYNH in Q2 2016 and held it in 11 quarters. The position peaked at $2.61M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Algert Global reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Algert Global sold 51,577 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.17M.
  • Algert Global first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 11 quarters.
  • Algert Global's Syneos Health, Inc. Class A Common Stock position peaked at $2.61M in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Algert Global's 13F filing for Q3 2023, filed 13 Nov 2023.